Characterization of broad-spectrum Mycobacterium abscessus class A -lactamase
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Characterization of broad-spectrum Mycobacterium abscessus class A -lactamase
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 69, Issue 3, Pages 691-696
Publisher
Oxford University Press (OUP)
Online
2013-10-18
DOI
10.1093/jac/dkt410
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MabsBase: A Mycobacterium abscessus Genome and Annotation Database
- (2013) Hamed Heydari et al. PLoS One
- Management of Nontuberculous Mycobacterial (NTM) Lung Disease
- (2013) David Griffith et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Macrolide Treatment forMycobacterium abscessusandMycobacterium massilienseInfection and Inducible Resistance
- (2012) Go-Eun Choi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Meropenem-Clavulanic Acid Shows Activity against Mycobacterium tuberculosis In Vivo
- (2012) Kathleen England et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inactivation of Mycobacterium tuberculosis l,d-Transpeptidase LdtMt1by Carbapenems and Cephalosporins
- (2012) Vincent Dubée et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical use of the meropenem-clavulanate combination for extensively drug-resistant tuberculosis [Case study]
- (2012) M. C. Payen et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Mycobacterium abscessus: a new antibiotic nightmare
- (2012) R. Nessar et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- World Health Organization Group 5 Drugs for the Treatment of Drug-Resistant Tuberculosis: Unclear Efficacy or Untapped Potential?
- (2012) K. E. Dooley et al. JOURNAL OF INFECTIOUS DISEASES
- Activity of Carbapenems Combined with Clavulanate against Murine Tuberculosis
- (2011) Nicolas Veziris et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary Disease
- (2011) Julie Jarand et al. CLINICAL INFECTIOUS DISEASES
- Fighting resistant tuberculosis with old compounds: the carbapenem paradigm
- (2011) J.L. Mainardi et al. CLINICAL MICROBIOLOGY AND INFECTION
- Meropenem/Clavulanate and Linezolid Treatment for Extensively Drug-resistant Tuberculosis
- (2011) Nicolas Dauby et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Clinical Outcome of Mycobacterium abscessus Infection and Antimicrobial Susceptibility Testing
- (2010) Yi-Ching Huang et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Mycobacterium abscessus: a new player in the mycobacterial field
- (2010) Halima Medjahed et al. TRENDS IN MICROBIOLOGY
- A Novel Gene, erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae
- (2009) K. A. Nash et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Non Mycobacterial Virulence Genes in the Genome of the Emerging Pathogen Mycobacterium abscessus
- (2009) Fabienne Ripoll et al. PLoS One
- Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis
- (2009) J.-E. Hugonnet et al. SCIENCE
- Identification of Functional Tat Signal Sequences in Mycobacterium tuberculosis Proteins
- (2008) J. A. McDonough et al. JOURNAL OF BACTERIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started